Richard Scalzo

Richard Scalzo

Former Senior Vice President, Head of Finance and AdministrationatDyne Therapeutics· In proxies 2024–2025

Pay in FY2024Dyne Therapeutics stock +77.1% the same year

Richard Scalzo was paid $2.5M in FY2024 (Dec). Dyne Therapeutics stock rose 77.1% that year.

Pay$100 in the stock at the end of FY23 → $177
Pay is from the Summary Compensation Table of each Dyne Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Dyne TherapeuticsPublic company · 2 yr
    • Former Senior Vice President, Head of Finance and Administration2024 – Present · 2 yrStock in role +34%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?